
Mesoblast Ltd
ASX:MSB

Intrinsic Value
The intrinsic value of one
MSB
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 1.65 AUD,
Mesoblast Ltd
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Mesoblast Ltd
Fundamental Analysis

Mesoblast carries heightened regulatory risk after repeated FDA delays and requests for more data on its lead candidate, Remestemcel-L, which could further prolong commercialization timelines and deplete financial resources.
If Remestemcel-L achieves FDA approval for pediatric steroid-refractory acute graft-versus-host disease, Mesoblast could secure a first-mover advantage in cell-based therapies for this life-threatening indication.

Revenue & Expenses Breakdown
Mesoblast Ltd
Balance Sheet Decomposition
Mesoblast Ltd
Current Assets | 69.7m |
Cash & Short-Term Investments | 37.7m |
Receivables | 3m |
Other Current Assets | 29m |
Non-Current Assets | 583.6m |
Long-Term Investments | 1.2m |
PP&E | 6.2m |
Intangibles | 574.9m |
Other Non-Current Assets | 1.3m |
Free Cash Flow Analysis
Mesoblast Ltd
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Mesoblast Ltd
Revenue
|
5.7m
USD
|
Cost of Revenue
|
5.8m
USD
|
Gross Profit
|
11.4m
USD
|
Operating Expenses
|
-91.6m
USD
|
Operating Income
|
-80.2m
USD
|
Other Expenses
|
-23.2m
USD
|
Net Income
|
-103.4m
USD
|
MSB Profitability Score
Profitability Due Diligence
Mesoblast Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Mesoblast Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
MSB Solvency Score
Solvency Due Diligence
Mesoblast Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Mesoblast Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MSB Price Targets Summary
Mesoblast Ltd
According to Wall Street analysts, the average 1-year price target for
MSB
is 3.42 AUD
with a low forecast of 2.42 AUD and a high forecast of 4.52 AUD.
Dividends
Current shareholder yield for MSB is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MSB
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 1.65 AUD,
Mesoblast Ltd
is
hidden
.